First results of the GMMG-CONCEPT trial for multiple myeloma

What is the role of autologous stem cell transplant in multiple myeloma?

Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma

PLEIADES: Daratumumab combinations for multiple myeloma

Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma

Treatment options for high risk relapsed/refractory multiple myeloma

BCMA: A new biomarker for multiple myeloma

ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma

Transitioning from bortezomib to ixazomib in patients with multiple myeloma

Implementing national cancer control plans

Chemoimmunotherapy or BTK inhibition for patients with CLL